IP Library Granted Patent US 9,636,393
Granted Patent B2
US 9,636,393 · App. 10/148,533 · Granted May 2, 2017

Compositions comprising

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,393
App. No.
10/148,533
Granted
May 2, 2017
Kind
B2
Abstract

International patent application WO99/61053 discloses immunogenic compositions that comprise N. meningitidis serogroup C oligosaccharide conjugated to a carrier, in combination with N. meningitidis serogroup B outer membrane protein. These are disclosed in the present application in combination with further Neisserial proteins and/or protective antigens against other pathogenic organisms (e.g. Haemophilus influenzae , DTP, HBV, etc.).

Claims (7)

1. A composition comprising (a) Neisseria meningitidis C (NmC) oligosaccharide conjugated to a carrier protein, (b) Neisseria meningitidis B (NmB) outer membrane protein, and (c) an isolated polypeptide comprising an amino acid sequence having 80% or greater sequence identity to SEQ ID NO: 601, wherein the components (a), (b) and (c) were mixed together and wherein the composition comprises a carrier-adjuvant selected from aluminum hydroxide, aluminum phosphate, and an oil-in-water emulsion.

2. The composition of claim 1 further comprising (d) a protective saccharide antigen against Neisseria meningitidis serogroup A.

3. The composition of claim 1 further comprising (d) a protective saccharide antigen against Neisseria meningitidis serogroup W.

4. The composition of claim 1 further comprising (d) a protective saccharide antigen against Neisseria meningitidis serogroup Y.

5. The composition according to claim 1 , wherein the NmB outer membrane protein is present as proteoliposomic vesicles.

6. The composition of claim 1 , wherein the carrier protein is CRM197.

7. A composition comprising (a) Neisseria meningitidis C (NmC) oligosaccharide conjugated to a carrier protein, (b) Neisseria meningitidis B (NmB) outer membrane protein, and (c) a polypeptide comprising an amino acid sequence having 80% or greater sequence identity to SEQ ID NO: 601, wherein the components (a), (b) and (c) were mixed together and the carrier protein is a non-toxic diphtheria toxin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 040077/0483 →